Read our latest press releases to learn how Gel4Med is making an impact in the life science ecosystem.
June 3, 2025
Gel4Med Awarded Mass Ventures START Grant to Accelerate Innovation in Tissue Engineering and Advanced Biomaterials Development.
May 27, 2025
Massachusetts General Hospital / Harvard Medical School publishes real-world evidence case series on G4Derm™ Plus biomimetic matrix (BMM™), highlighting rapid healing of diabetic foot ulcers (DFUs) refractory to advanced wound treatments.
July 9, 2024
Gel4Med, an innovative biomaterials company, is proud to announce that Podiatry Today has recognized their first product, G4Derm™ Plus, as one of the Top 10 Innovations in Podiatry.
May 01, 2024
Gel4Med and University of Miami funded to collaborate and innovate around novel treatments for Spinal Cord Injury.
October 05, 2023
The highly competitive National Institutes of Health Commercial Readiness Pilot (CRP) program awards Gel4Med with significant funding for the commercial launch of their lead asset.
October 23, 2023
Wound healing is a long-term, multistage biological process that includes hemostasis...
For press and media inquires, please email bd@gelformed.com
1660 Soldiers Field Road,
STE 7, #1063
Brighton MA 02135
M2D2 Umass Lowell, 110 Canal St, 4th Floor, Lowell MA 01852